by Bonnell Foundation | Feb 13, 2018 | News
February 12, 2018 — Vertex announced that the U.S. FDA approved SYMDEKO (tezacaftor/ivacaftor and ivacaftor) for treating the underlying cause of cystic fibrosis (CF) in people ages 12 and older who have two copies of...
by Bonnell Foundation | Mar 5, 2014 | Events, Featured
Join The Bonnell Foundation Thursday, May 8th, 2014 at CF Family Night. It’s a time to meet other CF parents, enjoy a casual dinner and hear from some CF experts. It will be informative, touching and inspirational. Our guests range from an attorney who can talk about...
